Ultrasound-Guided Stellate Ganglion Block With Botulinum
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
the local stellate ganglion block with bupivacaine and corticosteroid treatment for acute
peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local
therapy may be necessary and some time may ve ineffective. Our purpose in this study is to
evaluate therapeutic effects of stellate ganglion block (SGB) Botulinum Toxin on referactory
facial nerve palsy